🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with select trial: 20% mace reduction? Page 4

Has anyone dealt with select trial: 20% mace reduction?

Dr.SurgeonPGH Mon, Feb 2, 2026 at 6:00 AM 28 replies 808 viewsPage 4 of 6
tony_orlando
Member
234
1,123
Nov 2024
Orlando, FL
Feb 2, 2026 at 11:40 AM#16

Just wanted to say — for anyone reading this Has anyone dealt thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Feb 2, 2026 at 12:40 PM
23 9NauseaFreeNow, SteveThurs, B12Beth and 20 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Feb 2, 2026 at 11:57 AM#17

Dr.SurgeonPGH's experience with Has anyone dealt with resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 58 lbs in 13 months.

One thing I would add that Dr.SurgeonPGH did not mention: the mental health improvements were just as significant.

2 9PedsEndoPhilly, SleepDoc_PDX
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Feb 2, 2026 at 12:14 PM#18

Saving this for reference. Top-tier content.

5 22FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 2 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
Feb 2, 2026 at 12:31 PM#19

As a pharmacist, I want to add some clinical context to this discussion on Has anyone dealt with select trial 20%.

Building on what Dr.SurgeonPGH said — the evidence base here is robust. The key publications to reference are from the STEP program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
37 0NurseLeah_Nash, gary_naperville, sean_dublin and 34 others
Reply Quote Save Share Report
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Feb 2, 2026 at 12:48 PM#20

Subscribing to this thread. Has anyone dealt with is exactly what I've been researching. 🙏

Last edited: Feb 2, 2026 at 2:48 PM
47 4DataDave, Dr.GutHealth, amsterdam_pete and 44 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register